Abstract
Anticholinergic medications are commonly prescribed to older patients, particularly nursing home patients. Anticholinergic burden caused by these medications increases the risk of cognitive impairment, falls, delirium and increased mortality in this patient cohort. There are several published tools available to assess the impact of anticholinergic burden on patient negative outcomes (e.g. falls, cognitive impairment, hospitalisation, mortality). The Anticholinergic Cognitive Burden (ACB) scale is a validated tool which calculates a patient’s total anticholinergic medication score, to allow an estimation of cognitive burden.
| Original language | English |
|---|---|
| Pages | i32 |
| DOIs | |
| Publication status | Published - 13 Apr 2023 |
| Event | Health Services Research and Pharmacy Practice Conference 2023 - Bradford, United Kingdom Duration: 17 Apr 2023 → 18 Apr 2023 |
Conference
| Conference | Health Services Research and Pharmacy Practice Conference 2023 |
|---|---|
| Country/Territory | United Kingdom |
| City | Bradford |
| Period | 17/04/23 → 18/04/23 |
Keywords
- Medicine
- Anticholinergic
- Observational study
- Cohort
- Pharmacy
- Delirium
- Cognition
- Cohort study
- Anticholinergic agents
- Comorbidity
- Emergency medicine
- Family medicine
- Psychiatry
- Internal medicine
Fingerprint
Dive into the research topics of '491 Anticholinergic cognitive burden score in a cohort of nursing home patients; an observational study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver